Why is Aarti Pharma falling/rising?

As of 17-Jun, Aarti Pharmalabs Ltd is experiencing a decline in its stock price, currently at Rs 862.60, reflecting a decrease of Rs 11.4 or 1.3%. The stock has been on a downward trend, having fallen consecutively for the last three days, resulting in a total decline of 6.16% during this period. Despite this recent downturn, the stock has shown strong performance over the past month with an increase of 8.51%, and it has generated a substantial return of 42.26% over the past year. The company has a low Debt to EBITDA ratio of 0.63 times, indicating a strong ability to service its debt, and it has reported impressive financial metrics, including a record net sales figure of Rs 563.78 crore. However, the stock's long-term growth prospects appear limited, with net sales growing at an annual rate of only 4.27% over the last five years, and there has been a decrease in institutional investor participation, which may negatively impact investor confidence.
In the broader market context, Aarti Pharmalabs Ltd has outperformed the benchmark Sensex in the long term, with a year-to-date return of 25.51% compared to the Sensex's 4.41%. However, in the short term, the stock's performance has lagged behind the benchmark, as it has declined by 6.28% over the past week while the Sensex has only fallen by 0.98%. This disparity may reflect investor concerns regarding the company's recent performance and the declining interest from institutional investors, which could be contributing to the stock's current downward movement despite its strong historical returns and attractive valuation relative to peers.